SALT LAKE CITY, Sept. 19, 2013 /PRNewswire/ -- Remedy Informatics, the leading provider of registry-based software for healthcare delivery and life sciences research, will launch RemedyCHF™, the first offering in its forthcoming suite of heart and vascular products, at the 17 th Annual Scientific Meeting of the Heart Failure Society of America (HFSA). The meeting will take place Sept. 22-25, 2013 in Orlando, Florida. (Logo: http://photos.prnewswire.com/prnh/20130213/SF59513LOGO) RemedyCHF is the only clinical registry solution that captures data on heart failure patients across the entire continuum of inpatient, ambulatory and telephonic care. Serving as a single-source repository for all of an organization's CHF data, RemedyCHF can help both clinicians and researchers substantively and realistically address the increasing cost and burden of heart failure by delivering a true, 360-degree composite view of their heart failure population, regardless of setting. The product's capabilities will be demonstrated in the Remedy Informatics exhibit area (Booth #406) throughout the event. For more information on this and other products, or to request a demonstration of these informatics software solutions, please visit www.remedyinformatics.com. About Remedy Informatics Founded in 2003, Remedy Informatics, Inc. is a leading provider of registry-based oncology, cardiovascular and other informatics software products for life sciences research and healthcare delivery. The company, whose mission is to tangibly, measurably and permanently improve life sciences research and healthcare delivery around the world, serves a wide range of leading life sciences, translational research and healthcare institutions globally. Built on the innovative Mosaic™ Platform, all of Remedy's products are configurable and user-friendly. For more information visit: www.remedyinformatics.com. Media Contacts Kristofer Beldin, Remedy Informatics, (801) 733-3335 (office)/(801) 870-9407 (cell), firstname.lastname@example.org SOURCE Remedy Informatics, Inc.